Onyx Biotec Limited IPO, GMP, Details, Price, And Review

Onyx Biotec Limited, established in May 2005, is a pharmaceutical company that specializes in the production of sterile water for injections. In addition to manufacturing sterile water, the company also offers contract manufacturing services for a variety of pharmaceutical products, including dry powder injections and dry syrups.

These products are distributed both in the Indian market and internationally. Onyx Biotec's clients include prominent pharmaceutical companies such as Hetero Healthcare, Mankind Pharma, Sun Pharmaceutical Industries, Aristo Pharmaceuticals, Macleods Pharmaceuticals, Mapra Laboratories, Axa Parenterals, FDC Limited, Zuventus Healthcare, Akums Drugs, and Reliance Life Sciences, among others.

Onyx Biotec IPO Overview:

• ● Issue Size: ₹29.34 crores (entirely fresh issue)
• ● Total Shares: 48.1 lakh equity shares
• ● Price Band: ₹58 to ₹61 per share
• ● Minimum Lot Size: 2,000 shares (can be applied for in multiples of 2,000)
• ● IPO Opening Date: November 13, 2024
• ● IPO Closing Date: November 18, 2024
• ● Lead Manager: Horizon Management Private Limited
• ● Registrar: Mas Services Limited






WHAT IS GMP?

GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.

A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.

Onyx Biotec Limited IPO GMP

GMP Date	IPO Price	GMP	Last Updated
11-11-2024	61	5 (8.20%)	11-Nov-2024 14:50
09-11-2024	61	5 (8.20%)	09-Nov-2024 12:25

**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**




Onyx Biotec IPO Overview

Detail	Description
IPO Date	November 13, 2024 to November 18, 2024
Listing Date	[.]
Face Value	₹10 per share
Price Band	₹58 to ₹61 per share
Lot Size	2000 Shares
Total Issue Size	4,810,000 shares (aggregating up to ₹29.34 Cr)
Fresh Issue	4,810,000 shares (aggregating up to ₹29.34 Cr)
Issue Type	Book Built Issue IPO
Listing At	NSE SME
Shareholding pre issue	13,322,200
Shareholding post issue	18,132,200
Market Maker portion	244,000 shares




Onyx Biotec IPO Timeline (Tentative Schedule)

Detail	Description
IPO Open Date	Wednesday, November 13, 2024
IPO Close Date	Monday, November 18, 2024
Basis of Allotment	Tuesday, November 19, 2024
Initiation of Refunds	Wednesday, November 20, 2024
Credit of Shares to Demat	Wednesday, November 20, 2024
Listing Date	Thursday, November 21, 2024
Cut-off time for UPI mandate confirmation	5 PM on November 18, 2024




Onyx Biotec IPO Reservation

Investor Category	Shares Offered
QIB Shares Offered	Not more than 49.89% of the Net Issue
Retail Shares Offered	Not less than 35.04% of the Net Issue
NII (HNI) Shares Offered	Not less than 15.07% of the Net Issue




Onyx Biotec IPO Promoter Holding

Share Holding Pre Issue	88.60%
Share Holding Post Issue




Onyx Biotec Limited Financial Information

Period Ended	31 May 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,476.57	7,413.58	5,872.36	3,683.84
Revenue	1,054.11	5,387.43	3,961.65	4,498.09
Profit After Tax	130.77	303.16	184.46	335.29
Net Worth	2,618.64	2,487.87	1,820.16	1,637.59
Reserves and Surplus	1,286.42	1,155.65	1,230.00	1,047.43
Total Borrowing	3,156.14	3,078.04	2,922.83	1,224.39
Amount in ₹ Lakhs






Key Performance Indicator

KPI	Values
ROE	10.58%
ROCE	12.19%
Debt/Equity	1.24
RoNW	12.19%
Price/Earning P/E Ratio	N/A
PAT Margin (%)	5.64%

	Pre IPO	Post IPO
EPS (Rs)	2.28	4.33
P/E (x)	26.81	14.1




Objectives of Onyx Biotec IPO

The Company proposes to utilize the Net Proceeds from the Issue towards the following objectives:
• 1. Upgradation of existing manufacturing Unit I to manufacture large volume parenterals for intravenous use.
• 2. Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.
• 3. Prepayment or repayment of all or a portion of certain loans availed by the Company.
• 4. General Corporate Purposes.

FAQs for Onyx Biotec Services IPO

• What is the Onyx Biotec Services IPO?

  Onyx Biotec Services IPO is a SME IPO. The company is going to raise ₹29.34 Crores via IPO. The issue is priced at ₹58 to ₹61 per equity share. The IPO is to be listed on NSE.

• When will the Onyx Biotec Services IPO open for subscription?

  The IPO is to open on November 13, 2024 for QIB, NII, and Retail Investors. The IPO will close on November 18, 2024.

• What is Onyx Biotec Services IPO Investors Portion?

  The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.

• What is Onyx Biotec Services IPO Issue Size?

  Onyx Biotec Services IPO issue size is ₹29.34 crores.

• What is Onyx Biotec Services IPO Price Band?

  Onyx Biotec Services IPO Price Band is ₹58 to ₹61.

• What is Onyx Biotec Services IPO Lot Size?

  The minimum bid is 2000 Shares with ₹122,000 amount.

• What is the Onyx Biotec Services IPO Allotment Date?

  Onyx Biotec Services IPO allotment date is November 19, 2024.

• What is the Onyx Biotec Services IPO Listing Date?

  Onyx Biotec Services IPO listing date is November 21, 2024. The IPO is to list on NSE.

• What is Onyx Biotec Services current GMP?

  The current GMP of the Onyx Biotec Services is 5 (8.20%).




DRHP:

DRHP of Onyx Biotec Limited IPO




Read More IPO related blogs- Mangal Compusolution Limited IPO